Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Comput Sci Eng. 2012 Mar 7;94(6):521–539. doi: 10.1007/s00607-012-0191-2

Table 5.

Summary of challenges for Area 4

  • Data and knowledge integration at the nano level, different to what has been already done between clinical and –omics data at larger scales.

  • The structural nature of nanomaterials and the unknown effects of many nanoparticles must be investigated independently of ontological analyses

  • Imaging. A key issue is to create new contrast agents to target specific organs, functions, or cell types and new imaging methods that are based on nanotechnogical advances